+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Allergy Immunotherapies Market 2021-2025

  • ID: 5008937
  • Report
  • April 2021
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Aimmune Therapeutics Inc.
  • ALK-Abello AS
  • Allergy Therapeutics PLC
  • ASIT biotech
  • DBV Technologies SA
  • HAL Allergy BV
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the allergy immunotherapies market and it is poised to grow by $713.56 mn during 2021-2025, progressing at a CAGR of almost 8% during the forecast period. The report on allergy immunotherapies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of allergies, recent approvals and strong pipeline, and growing market consolidation.

The allergy immunotherapies market analysis includes product segment and geographic landscape.

The allergy immunotherapies market is segmented as below:

By Product
  • SCIT
  • SLIT

By Geography
  • Europe
  • North America
  • Asia
  • ROW

This study identifies the technological advances in allergy diagnostics as one of the prime reasons driving the allergy immunotherapies market growth during the next few years. Also, emerging drug development technologies and the growing popularity of slit will lead to sizable demand in the market.

The report on allergy immunotherapies market covers the following areas:
  • Allergy immunotherapies market sizing
  • Allergy immunotherapies market forecast
  • Allergy immunotherapies market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading allergy immunotherapies market vendors that include Aimmune Therapeutics Inc., ALK-Abello AS, Allergy Therapeutics PLC, ASIT biotech, DBV Technologies SA, HAL Allergy BV, Jubilant Life Sciences Ltd., LETI Pharma SLU, Merck KGaA, and Stallergenes Greer Ltd. Also, the allergy immunotherapies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aimmune Therapeutics Inc.
  • ALK-Abello AS
  • Allergy Therapeutics PLC
  • ASIT biotech
  • DBV Technologies SA
  • HAL Allergy BV

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Impact of COVID-19 on pharmaceuticals
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • SCIT - Market size and forecast 2020-2025
  • SLIT - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape
  • Overview

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • Europe - Market size and forecast 2020-2025
  • North America - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Overview
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Aimmune Therapeutics Inc.
  • ALK-Abello AS
  • Allergy Therapeutics PLC
  • ASIT biotech
  • DBV Technologies SA
  • HAL Allergy BV
  • Jubilant Life Sciences Ltd.
  • LETI Pharma SLU
  • Merck KGaA
  • Stallergenes Greer Ltd.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • SCIT - Market size and forecast 2020-2025 ($ million)
  • SCIT - Year-over-year growth 2020-2025 (%)
  • SLIT - Market size and forecast 2020-2025 ($ million)
  • SLIT - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Aimmune Therapeutics Inc. - Overview
  • Aimmune Therapeutics Inc. - Product and service
  • Aimmune Therapeutics Inc. - Key offerings
  • Aimmune Therapeutics Inc. - Key customers
  • Aimmune Therapeutics Inc. - Segment focus
  • ALK-Abello AS - Overview
  • ALK-Abello AS - Product and service
  • ALK-Abello AS - Key offerings
  • ALK-Abello AS - Key customers
  • ALK-Abello AS - Segment focus
  • Allergy Therapeutics PLC - Overview
  • Allergy Therapeutics PLC - Product and service
  • Allergy Therapeutics PLC - Key offerings
  • Allergy Therapeutics PLC - Key customers
  • Allergy Therapeutics PLC - Segment focus
  • ASIT biotech - Overview
  • ASIT biotech - Product and service
  • ASIT biotech - Key offerings
  • ASIT biotech - Key customers
  • ASIT biotech - Segment focus
  • DBV Technologies SA - Overview
  • DBV Technologies SA - Product and service
  • DBV Technologies SA - Key offerings
  • DBV Technologies SA - Key customers
  • DBV Technologies SA - Segment focus
  • HAL Allergy BV - Overview
  • HAL Allergy BV - Product and service
  • HAL Allergy BV - Key offerings
  • HAL Allergy BV - Key customers
  • HAL Allergy BV - Segment focus
  • Jubilant Life Sciences Ltd. - Overview
  • Jubilant Life Sciences Ltd. - Product and service
  • Jubilant Life Sciences Ltd. - Key offerings
  • Jubilant Life Sciences Ltd. - Key customers
  • Jubilant Life Sciences Ltd. - Segment focus
  • LETI Pharma SLU - Overview
  • LETI Pharma SLU - Product and service
  • LETI Pharma SLU - Key offerings
  • LETI Pharma SLU - Key customers
  • LETI Pharma SLU - Segment focus
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key offerings
  • Merck KGaA - Key customers
  • Merck KGaA - Segment focus
  • Stallergenes Greer Ltd. - Overview
  • Stallergenes Greer Ltd. - Product and service
  • Stallergenes Greer Ltd. - Key offerings
  • Stallergenes Greer Ltd. - Key customers
  • Stallergenes Greer Ltd. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aimmune Therapeutics Inc.
  • ALK-Abello AS
  • Allergy Therapeutics PLC
  • ASIT biotech
  • DBV Technologies SA
  • HAL Allergy BV
The publisher recognizes the following companies as the key players in the global allergy immunotherapies market: Aimmune Therapeutics Inc., ALK-Abello AS, Allergy Therapeutics PLC, ASIT biotech, DBV Technologies SA, HAL Allergy BV, Jubilant Life Sciences Ltd., LETI Pharma SLU, Merck KGaA, and Stallergenes Greer Ltd.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the technological advances in allergy diagnostics.'

According to the report, one of the major drivers for this market is the increasing prevalence of allergies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Aimmune Therapeutics Inc.
  • ALK-Abello AS
  • Allergy Therapeutics PLC
  • ASIT biotech
  • DBV Technologies SA
  • HAL Allergy BV
  • Jubilant Life Sciences Ltd.
  • LETI Pharma SLU
  • Merck KGaA
  • Stallergenes Greer Ltd.
Note: Product cover images may vary from those shown